fda glp-1 warning news november 2025 The New York Times spotlighted MEDVi. The had already warned the self-proclaimed 'fastest growing company in history.' 2025 Novel Small Molecule FDA

R.JarvisB

If and when these become available through a compliant pathway, the difference between a good outcome and a wasted one comes down to somebody reading the labs, sequencing the protocol around the person, and tracking whether it is actually working

But there are two main types of medications being prescribed for weight loss and diabetes: semaglutide and tirzepatide. Semaglutide is the generic name of the drug and is sold under two brand names: Ozempic used primarily for diabetes

Acetyl-L-carnitine (also called ALCAR) is the acetylated form

The pharmaceutical supply chain is well-established, with multiple FDA-approved formulations from major manufacturers